Modified 5-fluorouracil: Uridine phosphorylase inhibitor


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

5-Fluorouracil (5-FU) is a medication widely used in chemotherapy to treat various types of cancer. Being a substrate for the reverse reaction catalyzed by uridine phosphorylase (UPase), 5-FU serves as a promising prototype molecule (molecular scaffold) for the design of a selective UPase inhibitor that enhances the antitumor activity of 5-FU and exhibits intrinsic cytostatic effects on cancer cells. The chemical formula of the new compound, which binds to the uracil-binding site and, in the presence of a phosphate anion, to the phosphate-binding site of UPase, is proposed and investigated by molecular simulation methods.

作者简介

A. Lashkov

Shubnikov Institute of Crystallography of Federal Scientific Research Centre “Crystallography and Photonics”

编辑信件的主要联系方式.
Email: alashkov83@gmail.com
俄罗斯联邦, Leninskii pr. 59, Moscow, 119333

A. Shchekotikhin

Gause Institute of New Antibiotics

Email: alashkov83@gmail.com
俄罗斯联邦, ul. Bol’shaya Pirogovskaya 11, Moscow, 119021

A. Shtil

Blokhin Russian Cancer Research Center

Email: alashkov83@gmail.com
俄罗斯联邦, Kashirskoe sh. 23, Moscow, 115478

S. Sotnichenko

Shubnikov Institute of Crystallography of Federal Scientific Research Centre “Crystallography and Photonics”

Email: alashkov83@gmail.com
俄罗斯联邦, Leninskii pr. 59, Moscow, 119333

A. Mikhailov

Shubnikov Institute of Crystallography of Federal Scientific Research Centre “Crystallography and Photonics”

Email: alashkov83@gmail.com
俄罗斯联邦, Leninskii pr. 59, Moscow, 119333

补充文件

附件文件
动作
1. JATS XML

版权所有 © Pleiades Publishing, Inc., 2016